Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Cardiovascular Conditions and Diseases
      • Digital Health
      • Health Policy
      • Immunity and Infectious Diseases
      • Joint Health and Mobility
      • Respiratory and Lung Health
      • Spinal Cord Injury and Rehabilitation
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Hip Health and Mobility
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • Ovarian Cancer Research Centre
      • Vancouver Prostate Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Rehabilitation Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • CST Cerner at VCH
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Education and Training
      • Communications and Branding
      • Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Innovation and Partnership
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. Exercising to keep breast cancer from coming back

Exercising to keep breast cancer from coming back

Stories Aug 5, 2022 3 minutes

The endorphin rush and reduction in hormone therapy side effects from physical fitness could help patients stick to their medication.

Staying fit can lead to good feelings, and may also help support the long-term care and recovery of women with breast cancer, according to the results of a pilot study led by Vancouver Coastal Health Research Institute researcher Dr. Kristin Campbell.

Campbell’s team is now undertaking a larger study called the “Nutrition and exercise during cancer treatment (NExT) 2.0” study, aka BE-FIT 2.0, to investigate how an exercise program could make it easier for breast cancer survivors to adhere to their cancer-suppressing prescriptions.

“There are so many challenges associated with a diagnosis of breast cancer and the ensuing treatment,” says Campbell. “Women who have had breast cancer often need to receive endocrine therapy for five years or longer to support the prevention of a cancer recurrence, but this type of hormone therapy can come with troublesome side effects, such as bone, joint and muscle pain.”

Dr. Kristin Campbell is a physical therapist and a professor, the associate head of research and the director of the Clinical Exercise Physiology Laboratory in the Department of Physical Therapy at the University of British Columbia (UBC). She is also a member of the Centre for Hip Health and Mobility.

Among the approximate 68 Canadian women diagnosed with breast cancer every day, up to 50 per cent do not take their medication as prescribed.

“Many women stop taking their hormone therapy because of negative side effects, which puts them at risk of their cancer returning, growing or spreading.”

Preliminary evidence from a pilot study Campbell conducted before the larger BE-FIT 2.0 study showed that exercise may dampen some of these burdensome effects, removing a barrier that dissuades some women from sticking to their hormone therapy.

Movement for improving side effects of cancer treatment and community connection

Campbell’s BE-FIT 2.0 study aims to recruit around 140 breast cancer survivors between the ages of 18 and 75.

Half of the research participants in the randomized controlled trial are entered into an “immediate exercise” group that receives twice-weekly 45-minute group-based exercise classes for eight weeks. The other half of participants receive the BE-FIT 2.0 exercise training after an initial eight weeks of regular treatment without the exercise component.

The group classes focus on muscle strengthening and circuit training, and also give participants opportunities for socialization.

“Participants have all gone through similar experiences, and can connect with each other and find social support and a sense of belonging.”

“We have seen women taking the exercise classes start feeling better, perhaps because they are proactively taking charge of their care,” adds Campbell.

BE-FIT 2.0 is being delivered online due to COVID-19 restrictions, which has the added benefit of improving accessibility and allowing women from across British Columbia to participate.  

"The goal of this research is to show that exercise can help improve medication adherence, thereby supporting a better chance of survival among women diagnosed with breast cancer.”

At a physical level, exercise gets the heart pumping and blood flowing, releasing endorphins that can block pain receptors in the brain. This can also help to combat other side effects of endocrine therapy, such as bone loss, says Campbell.

“We have seen the benefits that programs like BE-FIT 2.0 can have, and there is a great desire among medical oncologists to give more women access to services like this.”

Visit the Cancer Exercise Research website for more resources for patients and clinicians, including sample prescription pads, cheat sheets on the latest guidelines and upcoming clinical trial recruitment information.

Oncology and self-referrals are currently being accepted to the BE-FIT clinical trial. Contact research manager Kelly Mackenzie at kelly.mackenzie@ubc.ca or 1-250-897-2609 to learn more.
 

Researchers

Kristin Campbell

Related Articles

A new phase in prostate cancer research

Novel discovery slowed prostate cancer growth by targeting its sugar coat

With just a tablespoon of blood, B.C. researchers aim to transform cancer treatment

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Related Research Centres/Programs

Centre for Hip Health and Mobility

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

VCHRI researchers awarded CIHR project grants to support health research

Feb 2, 2023
Type
Stories

Early intervention with cryoablation for better heart outcomes

Jan 22, 2023 cardiac, treatment options, stroke
Type
Stories

Keeping your head in the race: Cognitive impacts observed among ultra-marathon runners

Jan 20, 2023 cardiac, cognition, safety
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • Twitter
  • LinkedIn

© 2023 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy